First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid Tumor
Clinical trial NCT01156870 · COMPLETED
Trial details
- NCT number
- NCT01156870
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-08
- Primary completion
- 2017-04-07
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.